menu search

Kodiak sciences discontinues development of eye disorder therapeutic; shares plummet

Kodiak Sciences shares fell by more than 45% after the biopharmaceutical company announced that it was discontinuing its tarcocimab program for eye di...

July 24, 2023, 1:59 pm

Weekly forex analysis july 24 – 28 – fomc interest rate decision, and crypto anticipation

A possible turnaround is on the horizon of the CHF The trading rooms are the opportunity to trade together with our traders! The rooms are available f...

July 24, 2023, 1:54 pm

Amc: is a big squeeze in the coming attractions?

Nearly eight million moviegoers worldwide visited an AMC Theater over the highly anticipated "Barbenhei...

July 24, 2023, 1:50 pm

Bonds gain, stocks muted after weak european data: markets wrap

Global bonds rallied and stock markets were muted Monday, as sharp declines in manufacturing and services gauges across Europe fanned concerns about e...

July 24, 2023, 1:48 pm

Gold price upside looks restricted as investors anticipate hawkish monetary policy

Contrary to Powell’s commentary, investors are hoping that July’s rate hike would be the last nail in the coffin. Also, Goldman Sachs cited that t...

July 24, 2023, 1:14 pm

Here's what to expect from acadia healthcare's (achc) q2 earnings

Acadia Healthcare's (ACHC) Q2 results are likely to reflect increased patient volumes across its U.S. o...

July 24, 2023, 1:05 pm

Panbela opens enrollment in uk and germany for aspire trial in pancreatic cancer, all countries/regions in the aspire trial are now open and actively enrolling

Interim Data Analysis anticipated in Early 2024 MINNEAPOLIS, July 24, 2023 (GLOBE NEWSWIRE) — Panbela...

July 24, 2023, 12:15 pm

Eurchf bears’ patience rewarded for now

EURCHF is trading at a new 2023 low as the breakout from the 10-month-old rectangle appears to be valid. This is the lowest EURCHF print since Septemb...

July 24, 2023, 12:01 pm

Nasdaq 100 technical: bullish exhaustion sighted

Last week, Nasdaq 100 underperformed against the other major US stock indices. Nasdaq 100 failed to have a weekly close above 15,690 key medium-term r...

July 24, 2023, 11:55 am

Gold prices in holding pattern as investors await fed meeting

Gold prices were little changed on Monday as a busy week for markets begins, with investors waiting to hear from Federal Reserve Chairman Jerome Powel...

July 24, 2023, 11:44 am

Here's why kura sushi (krus) is a great 'buy the bottom' stock now

Kura Sushi (KRUS) witnesses a hammer chart pattern, indicating support found by the stock after losing ...

July 24, 2023, 11:36 am

Nasdaq 100 technical: bullish exhaustion sighted

Last week, Nasdaq 100 underperformed against the other major US stock indices. Nasdaq 100 failed to have a weekly close above 15,690 key medium-term r...

July 24, 2023, 11:20 am

Cloud dx on track to double sales in 2023 with signing of record-breaking 20th contract

Cloud DX (TSX-V:CDX, OTCQB:CDXFF) said it expects to double its sales in 2023 over 2022 with 20 new contracts or contract expansions announced so far ...

July 24, 2023, 11:20 am

Eurusd backs off after new 2023 high

EURUSD has been on a downward path since registering on July 18 a new 2023 high, which is also the high...

July 24, 2023, 11:10 am

Nasdaq 100, dow jones, s&p 500: investors await fed’s decision amid earnings rush

U.S. stock index futures show stability as investors eagerly anticipate key earnings reports and the Fe...

July 24, 2023, 11:00 am

Microsoft stock plunges ahead of the q4 earnings report

In the lead-up to Microsoft's much-anticipated earnings report for the fourth financial quarter, the te...

July 24, 2023, 10:46 am

Annexon to report archer phase 2 trial results in geographic atrophy at asrs 2023

Company to hold investor conference call on Monday, July 31, 2023 at 1:30 p.m. PT / 4:30 p.m. ET BRISBANE, Calif., July 24, 2023 (GLOBE NEWSWIRE) — ...

July 24, 2023, 10:30 am

Gilead sciences shares decline after it discontinues blood cancer treatment trial

Gilead Sciences, Inc. (NASDAQ:GILD) started on the back foot on Monday after the biopharmaceutical company told investors it has discontinued its Pha...

July 24, 2023, 10:27 am

What's in the offing for cms energy (cms) in q2 earnings?

CMS Energy's (CMS) Q2 results are likely to reflect mixed weather pattern impacts amid wildfire-related...

July 24, 2023, 10:06 am

Belite bio completes enrollment in pivotal global phase 3 dragon trial evaluating oral tinlarebant for stargardt disease

Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in ...

July 24, 2023, 10:04 am


Search within

Pages Search Results: